StonvexLoading…
StonvexStonvexStonvexCore line items from ENVA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.15B | $2.66B | $2.12B | $1.74B |
Operating Income | $739.43M | $584.76M | $422.13M | $383.99M |
Net Income | $308.39M | $209.45M | $175.12M | $207.42M |
EPS (Diluted) | $11.52 | $7.43 | $5.49 | $6.19 |
Total Assets | $6.47B | $5.27B | $4.59B | $3.78B |
Total Liabilities | $5.13B | $4.07B | $3.35B | $2.59B |
Cash & Equivalents | $71.71M | $73.91M | $54.36M | $100.17M |
Free Cash Flow OCF − CapEx | $1.77B | $1.50B | $1.12B | $850.37M |
Shares Outstanding | 24.72M | 25.81M | 29.09M | 31.22M |